Cleared Traditional

K862630 - MYCOPLASMA PNEUMONIAE ANTIBODY LATEX TEST SYSTEM
(FDA 510(k) Clearance)

Sep 1986
Decision
55d
Days
Class 1
Risk

K862630 is an FDA 510(k) clearance for the MYCOPLASMA PNEUMONIAE ANTIBODY LATEX TEST SYSTEM. This device is classified as a Antisera, All Mycoplasma Spp. (Class I - General Controls, product code GSA).

Submitted by Medical Diagnostic Technologies, Inc. (Augusta, US). The FDA issued a Cleared decision on September 3, 1986, 55 days after receiving the submission on July 10, 1986.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3375.

Submission Details

510(k) Number K862630 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 10, 1986
Decision Date September 03, 1986
Days to Decision 55 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary

Device Classification

Product Code GSA — Antisera, All Mycoplasma Spp.
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3375